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ABSTRACT: Pseudaminic acid (Pse5Ac7Ac) is a non-mammalian 
sugar present on the cell surface of a number of bacteria including 
Pseudomonas aeruginosa, Campylobacter jejuni and Acinetobacter 
baumannii. However, the role Pse5Ac7Ac plays in host-pathogen 
interactions remains underexplored, particularly compared to its 
ubiquitous sialic acid analogue Neu5Ac. This is primarily due to a 
lack of access to difficult to prepare Pse5Ac7Ac glycosides. Herein 
we decribe the in vitro biocatalytic transfer of an activated 
Pse5Ac7Ac donor onto glycosyl acceptors enabling the enzymatic 
synthesis of Pse5Ac7Ac containing glycosides. In a chemoenzymat-
ic approach, chemical synthesis initially afforded access to a late stage Pse5Ac7Ac biosynthetic intermediate, which was subse-
quently converted to the desired CMP-glycosyl donor in a one-pot-two-enzyme process using biosynthetic enzymes. Finally screen-
ing a library of 13 sialyltransferases (SiaT) with the unnatural substrate enabled the identification of a promiscuous inverting SiaT 
capable of turnover to afford β-Pse5Ac7Ac terminated glycosides.
INTRODUCTION 
Nonulosonic acids (NulOs) are nine-carbon α-keto-acid 
sugars that are ubiquitous in nature, occurring in several cell 
surface glycoconjugates where they play a crucial role in cell-
cell interactions.
1-4
 One nonulosonic acid of particular interest 
is non-eukaryotic α-5,7-diacetamido-3,5,7,9-tetradeoxy-ʟ-
glycero-ʟ-manno-non-2-ulosonic acid, or pseudaminic acid 
(Pse5Ac7Ac 1), and its derivatives.
5
 Upon its discovery within 
the lipopolysaccharide O-antigen of Pseudomonas aeruginosa 
and Shigella boydii in the mid-1980s,
6
 it was noted that 
Pse5Ac7Ac 1 possesses structural similarities to the widely 
prevalent N-acetyl neuraminic acid (Neu5Ac)
7
 2 (Figure 1, 
which has ᴅ-glycero-ᴅ-galacto stereochemistry).
8
 A number of 
derivatives differentially substituted at the N5 or N7 positions 
of the Pse backbone have subsequently been identified in a 
range of glycoconjugates attached through both axial and 
equatorial glycosidic linkages,
9-11
 in several multidrug resistant 
pathogens
5
 where they play a crucial role in virulence.
5, 12-14
  
Neu5Ac 2 often exists as the terminal sugar on human cell 
surface glycoconjugates, and is therefore an accessible binding 
site for invaders, such as the influenza virus,
15
 but also for 
interactions with host proteins, specifically Siglecs which are 
lectins primarily present on host immune cells.
16
 Siglecs play 
an integral role in immune tolerance and help the immune 
system to recognise Neu5Ac and interpret its presence on the 
cell as a sign of “self”,
17
 a mechanism which can be exploited 
by bacteria able to camouflage themselves in surface Neu5Ac 
and evade immune detection in an example of “molecular 
mimicry”.
18
 Despite its structural similarity to Neu5Ac 2 and 
Figure 1 Nonulosonic acid structures; the pseudaminic acid 
Pse5Ac7Ac 1, and sialic acid Neu5Ac 2. 
 
aforementioned presence on pathogenic bacterial cell surfaces, 
there are precious few studies
19
 exploring how Pse5Ac7Ac 1 
might bind to host proteins compared to Neu5Ac 2, and there-
fore if bacteria employ Pse glycans to aid immune evasion. 
Such studies have been hindered by a lack of access to Pse-
glycosides, specifically those which mimic natural Neu5Ac 
capped glycoconjugates and would provide a means to com-
pare the effects of a terminal Neu5Ac or Pse5Ac7Ac architec-
ture on glycan-receptor interactions.  This is because produc-
tion of Pse glycosides by purely chemical methods is rare, and 
although impressively elegant, all reported strategies to date 
have been multi-step resulting in a low overall yield, and face 
additional challenges in controlling the stereochemistry of 
Pse-glycosidic linkages during glycosylation.
20-27
 Conversely, 
the highly stereo- and regioselective nature of enzymatic gly-
cosylation make it an attractive route to Pse-glycosides.  In 
vivo studies have tentatively identified glycosyltransferases 
proposed to utilise CMP-Pse donors (pseudaminyltransferases) 
in a range of bacteria.
28, 29
 However, currently no direct in vitro 
enzymatic transfer of CMP-Pse using a glycosyltransferase 
has been reported. Furthermore the sole in vitro enzymatic 
synthesis of CMP-Pse5Ac7Ac 3 in the literature is prohibitive-
ly expensive requiring both costly UDP-GlcNAc starting ma-
terial and an acetyl-CoA cofactor in the early steps in the 
pathway (Scheme 1).
30
   
Therefore to facilitate future comparisons of the effects of 
Neu5Ac and Pse5Ac7Ac capped glycoconjugates on protein 
binding interactions, herein we address the lack of practical 
procedures to Pse-glycosides through the union of both chemi-
cal and enzymatic synthesis. Concluding with the transfer of 
CMP-Pse5Ac7Ac 3 onto a range of glycosyl acceptors exploit-
ing a promiscuous sialyltransferase to afford β-2,3/2,6-linked 
Pse di- and trisaccharides mimics. We initially targeted the 
chemical synthesis of 6-deoxy-L-AltdiNAc 4 (Scheme 1), a 
biosynthetic precursor of Pse5Ac7Ac 1, and a  substrate for 
PseI, a Pse5Ac7Ac synthase.
12, 31
 Our aim was to utilise PseI 
in combination with PseF, a CMP-Pse5Ac7Ac acid synthe-
tase,
30
 in a one-pot procedure to synthesise CMP-Pse5Ac7Ac 
3 from the reducing sugar 4. The CMP-sugar 3 could then be 
used as a potential glycosyl donor in a sialyltransferase 
(SiaTs) activity screen, with the aim of identifying promiscu-
ous enzymes capable of synthesising Pse containing glyco-
sides. 
 
RESULTS AND DISCUSSION 
Chemical synthesis of 6-deoxy-L-AltdiNAc 4. We estab-
lished an efficient chemical route to 6-deoxy-L-AltdiNAc 4 
starting from the readily synthesised L-fucoside 5 (Scheme 
2).
32
 The synthesis required a triple inversion of stereochemis-
try at the 2, 3, and 4 positions, with the order in which these 
inversions were performed proving crucial to success. Follow-
ing global deacetylation of 5, regioselective O-3 benzoylation 
was achieved with diphenyl borinate to afford the L-fucosyl 
2,4-diol 6. Treatment of 6 with Tf2O in pyridine yielded a 2,4-
bis-triflate, which was then treated with NaN3 to access the 
rare deoxy-amino-˪-mannose derivative 7 via double, parallel 
inversions.
33
 Notably when double inversions were attempted 
on the O-3 benzoyl epimer of 6, only decomposition was ob-
served, presumably due to the axial benzoyl group increasing 
steric hindrance during equatorial attack of O-4, as previously 
also noted by Ito and co-workers.
24
 Debenzoylation afforded 
compound 8, which was then trifylated at O-3 to produce an 
intermediate triflate, and once more subjected to inversion 
without purification through treatment with TBANO2. The 
reaction proceeded cleanly and 2,4-di-azido altropyronaside 9 
was isolated in 46% yield, over two steps. However, we noted 
that if the α-anomer of 8 was treated under similar conditions, 
or subjected to oxidation and subsequent hydride reduction, no 
inversion of steroechemistry at O-3 was observed in our 
hands, likely a result of unfavourable 1,3-diaxial in teraction 
experienced during axial attack upon O-3. Staudinger reduc-
tion of the 2,4-di-azido altropyronaside 9 with PMe3,
 
followed 
Scheme 2 Chemical synthesis of 6-deoxy-L-AltdiNAc 4. a) i) NaOMe, MeOH. ii) Diphenyl borinate, DIPEA, BzCl, CH3CN, 80% over 2-
steps. b) i) Tf2O, Pyridine, DCM, 0 °C. ii) NaN3, DMF, 110 °C, 58% over 2-steps. c) NaOMe, MeOH, 95%. d) i) Tf2O, Pyridine, DCM, 0 
°C. ii) TBANO2, CH3CN, 70 °C, 46% over 2-steps. e) i) PMe3, NaOH, THF, 60 °C. ii) Ac2O, Pyridine, 69% over 2-steps. f) NaOMe, 
MeOH, 81%. g) CAN, CH3CN:H2O (4:1 v/v), 94%, α:β 1:3. 
Scheme 1 Biosynthesis of CMP-Pse5Ac7Ac 3 via the key hexose 
intermediate 6-deoxy-ʟ-AltdiNAc 4. PLP =  pyridoxal 5'-
phosphate; L-Glu = L-glutamate; PEP = phosphoenolpyruvate; 
CTP = cytidine monophosphate. 
 
by acetylation, afforded compound 10, which was then selec-
tively O-deacetylated to afford 2,4-di-acetamido altro-
pyronaside 11. Ceric ammonium nitrate assisted deprotection 
of the anomeric methoxyphenyl group finally yielded the de-
sired 6-deoxy-AltdiNAc reducing sugar 4 in an 11% overall 
yield. 
Enzymatic production of CMP-Pse5Ac7Ac 3. Synthesis 
of the desired CMP-Pse5Ac7Ac 3 nucleotide donor was 
achieved utilizing the final two enzymes from the biosynthetic 
pathway; PseI and PseF (Figure 2). C. jejuni PseI was initially 





 Sequence alignment with H. pylori 
PseF
34
 revealed a putative CMP-Pse5Ac7Ac synthetase gene 
present in the gram-negative Aeromonas caviae genome.
28
 
Subsequent expression of A. caviae PseF was optimised and 
resulted in the purification of soluble enzyme affording 13 mg 
L
-1
 (Figure 2a). Activity of the Pse5Ac7Ac synthase PseI was 
monitored by negative ion electrospray ionization (ESI) LC-
MS during incubation with 6-deoxy-L-AltdiNAc 4 at pH 7.4 
with a small excess of the required phosphoenol pyruvate co-
factor.
31
 A peak associated with production of Pse5Ac7Ac 1 
([M-H]
-
 333) was immediately observed without addition of 
exogenous divalent metal ions (Figure S2). Upon addition of 
A. caviae PseF to the reaction mixture with excess CTP and 
MgCl2 a peak associated with the production of CMP-
Pse5Ac7Ac 3 ([M-H]
-
 638) was observed. Hence demonstrat-
ing that CMP-Pse5Ac7Ac 3 can be enzymatically produced in 
one-pot from chemically synthesized 6-deoxy-L-AltdiNAc 4 
(Figure 2c). The reaction was stopped after four hours and the 
product purified by size exclusion chromatography (Bio-Gel
®
 
P-2 resin Biorad), NMR and LC-MS characterization of the 
enzymatic product by comparison to previously published data 
confirmed the synthesis of αCMP-Pse5Ac7Ac 3 (Figure S25-
26).
30
 Calculation of the difference in chemical shift between 
the H3ax and H3eq (Δppm H3eq−H3ax = 0.62 ppm) was indica-




Sialyltransferase activity screen using α-CMP-
Pse5Ac7Ac 3. In vitro studies of well-characterised sialyl-
transferases (SiaTs) have shown that a number of enzymes 
have promiscuity towards both the donors and acceptors they 
can turnover. A range of natural and bioorthogonal tagged 
CMP-Neu5Ac derivatives and other CMP-nonulosonic acids 
(such as CMP-Leg5Ac7Ac) have previously been utilised as 
donors.
6, 35, 37-38
 Pse5Ac7Ac 1 differs from Neu5Ac 2 function-
ally; C7 has an acetamido and C9 loses a hydroxyl, and stere-
ochemically; C5, C7 and C8 are epimeric. However SiaT 
promiscuity had previously been observed with sugars that 
include some of these modifications, C9 deoxy
37
 and C7 N-
acyl
38
 sugars for example, therefore it was reasoned that these 
enzymes may also be functional in the chemoenzymatic  syn-
thesis of Pse5Ac7Ac-based glycosides. A library of 13 bacte-
rial SiaTs were therefore screened for their ability to utilise 
αCMP-Pse5Ac7Ac 3 as a glycosyl donor, including the three 
enzymes that had previously shown activity towards CMP-
Leg5Ac7Ac.
37, 39
 A range of characterised and putatively as-
signed SiaTs were considered (Table S1), from three different 
GT families; GT42, GT52 and GT80, with an imidazolium 
tagged-N-acetyllactosamine (LacNAc-ITag)
40
 12 acceptor 
(Scheme 3). Two SiaTs chosen had previously been shown to 
catalyse the glycosylation of CMP-Neu5Ac and a LacNAc 
derivative labelled with a N-benzenesulfonyl-type ITag,
41
 
which bears a similar imidazolium label to LacNac-ITag 12.  
The use of the cationic ITag label decreases the mass spec-
trometry detection limit for observing reaction components 
and increases the spectral peak intensity of LacNAc-ITag con-




Figure 2 a) 12% SDS PAGE analysis of purified enzymes; Lane
1: Molecular weight ruler, Lane 2: C. jejuni PseI (40.8 kDa), Lane
3: A. caviae PseF (28.0 kDa) b) Negative ESI LC-MS for the one-
pot, two enzyme synthesis of CMP-Pse5Ac7Ac 3 from 6-deoxy-
AltdiNAc 4 c) Use of the chemically derived 6-deoxy-L-AltdiNAc
4 in the one-pot enzymatic synthesis of CMP-Pse5Ac7Ac 3.	
Figure 3 The chemical shift of the H3eq (2.23 ppm) and H3ax (1.61
ppm) proton NMR peaks used to assign the PseF enzymatic product
as αCMP-Pse5Ac7Ac 3. 
 
Reaction conditions were identical for all SiaTs; incubating 
a 1:4 ratio of donor to acceptor at pH 7.5, for 18 hours. Analy-
sis of ITag containing compounds with MALDI-ToF showed 
starting material remained in all reactions but an additional 
peak was present with four enzymes (all GT80), which was 
assigned to the desired Pse5Ac7Ac-LacNAc-ITag (m/z 985.4) 
(Table S1, Figure S3). Based on the reported enzymatic char-
acterisation of these enzymes, under these reaction conditions 





 and truncated Pasteurella multocida
38
 
SiaTs would all catalyse production of the β-2,3-linked glyco-
side 13 and the Photobacterium leiognathi
47
 SiaT would result 
in a β-2,6-linked glycoside 14. Not all SiaTs tested herein have 
previously been characterised and hence negative hits are to be 
treated with caution as pseudo-pseudaminyltransferase activity 
may also be possible under alternate conditions.
38
  
To corroborate the MALDI-TOF results for the positive 
hits, the same reactions were analysed using negative ESI LC-
MS (Figure S4), and in all cases no remaining CMP-
Pse5Ac7Ac 3 starting material was detected. Considering the 
Pasteurella multocida SiaT (tPm0188Ph) affords β-2,3-linked 
glycosides at pH 7.5,
 
 but can also potentially be tuned to pro-
duce α2-6-glycosides under different conditions,
38 
it was cho-
sen for further investigation. Specifically, αCMP-Pse5Ac7Ac 
3 was screened with a range of galactose acceptors 15-20, in a 
1:4 donor to acceptor ratio (Table 1) to profile tPm0188Ph 
acceptor promiscuity.	 Negative ESI UPLC-MS standard 
curves for Pse5Ac7Ac 1 and αCMP-Pse5Ac7Ac 3 at known 
concentrations (Figure S5) were used to calculate the level of 
conversion to the glycoside product by determining the 
amount of unreacted material present. In 4 h experiments high 
levels of conversion (>75%) were achieved with five of the 
galactose-based acceptors 15, 17-20 (Table 1). Similar to re-
sults previously obtained with the CMP-Neu5Ac donor, Lac-
tose 18 and LacNAc 19 were accepted particularly well by this 
enzyme (90% and 91% conversion respectively),
38
 as was 
Galβ-pNP 20 (91% conversion). This was significantly higher 
than with monosaccharides 15 and 17, presumably as 18-20 
more closely mimic the structure of the native disaccharide 
acceptor.
48
 A 57% conversion was also observed with the un-
natural 6F-galactose 16 demonstrating that under the reaction 
conditions screened the P. multocida enzyme is indeed likely 
forming a 2,3-linkage. It was proposed that the reduction of 
activity with 6F-galactose 16 could be attributed to a loss of 
hydrogen bonding to Asn85 that is predicted in the galactose 
binding region with the native C6-OH.
48
 A time-course exper-
iment using LacNAc acceptor 19 demonstrated that the ma-
jority of the αCMP-Pse5Ac7Ac 3 donor was turned over to 
glycoside product within 1 h (Figure S10), and although some 
formation of hydrolysis product Pse5Ac7Ac 1 was observed 
by negative ion LCMS, the relative proportion did not change 
over the course of the reaction (0-4 h) suggesting minimal 
enzymatic hydrolysis of the donor. 
Docking
49
 of αCMP-Pse5Ac7Ac 3 into the P. multocida 
crystal structure
48
 showed that this donor could be accepted in 
a conformation analogous to that reported for bound CMP-
3F(a)Neu5Ac (Figure 4.a) reinforcing the donor promiscuity 
observed experimentally. Previous donor-bound crystal struc-
tures highlight that the majority of interactions occur with the 
nucleotide moiety which is buried within the enzyme active 
site,
48
 docking of αCMP-Pse5Ac7Ac 3 does not disturb any of 
these interactions, despite a slight perturbation of the phos-
phate group (Figure S7). Importantly when αCMP-Pse5Ac7Ac 
3 is docked in its lowest energy conformation with the CMP 
moiety occupying this site, there is no steric clashes between 
the Pse5Ac7Ac sugar moiety and the enzyme (Figure 4.b). 
Similarly, the binding affinity of docked αCMP-Pse5Ac7Ac 3 
(-10 kcal mol
-1
) was only marginally lower than docked 
βCMP-Neu5Ac (-10.2 kcal mol
-1
) suggesting that any loss of 
binding interactions due to structural differences are compen-
sated for by other interactions. However, it is notable that in a 
direct competition experiment between the βCMP-Neu5Ac 
and αCMP-Pse5Ac7Ac 3 donors in the presence of LacNAc 
acceptor 19 formation of 10-fold greater Neu5Ac-LacNAc 
over Pse5Ac7Ac-LacNAc was observed (Figure S8), indicat-
ing that in vitro the P. multocida enzyme has an established 
preference for the Neu5Ac scaffold. 
Co-crystallisation with CMP-3F(a)Neu5Ac previously iden-
tified five hydrogen bonds (two water-mediated) and one ion 
pair interaction between the Neu5Ac moiety and enzyme.
48
 
Analysis of αCMP-Pse5Ac7Ac docked into tPm0188 shows 
that there are also five hydrogen bonds (one water-mediated) 
and one ion pair interaction possible, albeit to different resi-
Scheme 3 SiaT catalyzed transfer of CMP-Pse5Ac7Ac 3 onto LacNAc-ITag 12. 
Table 1 Pasteurella multocida pseudo-pseudaminyltransferase
(tPm0188Ph) catalyzed transfer of α-CMP-Pse5Ac7Ac 3 onto 
galactose-based acceptors (15-20). 
 
dues in the active site in some cases (Figure 5). The C2 car-
boxyl is orientated to allow for ion pair interactions with 
Arg63 in both Neu5Ac and Pse5Ac7Ac, similarly the C4 hy-
droxyl in both molecules can form an H-bond with the Asp141 
carbonyl backbone. The Trp270 side chain forms a H bond 
with both Neu5Ac and Pse5Ac7Ac moieties, the C7 hydroxyl 
and C5 acetamido carbonyl respectively, which occupy a simi-
lar space due to the opposing stereochemistry at these two 
centres. In Pse5Ac7Ac, the C5 acetamido group forms a se-
cond H bond with the amine proton interacting with the 
Asp141 side chain carbonyl in this configuration, whereas this 
H bond is to Ser143 in Neu5Ac. The C8 hydroxyl in both 
molecules form H bonds, a water mediated bond occurs with 
Thr267 in Neu5Ac, however in Pse5Ac7Ac the C8 hydroxyl 
can directly interact with His311 due being epimerised at this 
position. Finally, the Pse5Ac7Ac C7 acetamido group has a 
water mediated H bond between the carbonyl moiety and the 
backbone carbonyl of Ala354.  
 
tPm0188Ph catalyzed synthesis of Pse5Ac7Acβ-2,3-Galβ-
pNP 21. The P. multocida enzyme (tPm0188Ph) has previous-
ly been shown to act as an inverting SiaT transferring βCMP-
Neu5Ac to galactosides to preferentially make an α-2,3-
linkage at pH 7.5-9.0 or an α-2,6-linkage at pH 5.0-5.5.
38
 
Therefore a β-2,3-Pse5Ac7Ac-galactoside would be the pre-
dicted product when using tPm0188Ph with αCMP-
Pse5Ac7Ac 3 under the reaction conditions employed (pH 7.5) 
(Scheme 4). However further characterisation of the 
pseudaminyl galactoside was required to confirm the regio- 
and stereo- selectivity of the pseudo-pseudaminyl transferase 
activity. Therefore a preparative scale reaction containing 
αCMP-Pse5Ac7Ac 3 (9.5 mg), four equivalents of Galβ-pNP 
20 (20.5 mg) and tPm0188Ph was used to afford enough prod-
uct for purification and characterization (see SI for full de-
tails). PseF, CTP and MgCl2 were also included in the reaction 
mixture to recycle any hydrolysed Pse5Ac7Ac 1 into αCMP-
Pse5Ac7Ac 3 and drive the reaction towards the product. The 
reaction was stopped when after 18 hours (conversion > 90%) 
and following purification, NMR analysis confirmed the prod-
uct as β-2,3-Pse5Ac7Ac-Galβ-pNP 21 (Figure S27-28), 
formed in a 2.1 mg (23 %) yield. 
13
C NMR comparison of the 
Galβ-pNP 20 and product 21 revealed a downfield chemical 
shift of the galactose C3 by 2.65 ppm, with no significant ga-
lactose C6 chemical shift perturbation, indicative of glycosyla-
tion at the galactose C3.
38
 Once again, the anomeric stereo-
chemistry was assigned using the difference in chemical shift 
between the H3ax and H3eq with a value of Δppm H3eq−H3ax = 






This work provides the first examples of chemoenzymati-
cally synthesised Pse containing glycosides, which are in in-
a) b
)
Figure 4 αCMP-Pse5Ac7Ac 3 (green cylinder model) docked into Pasteurella multocida tPm0188Ph (coral) a) overlaid with CMP-
Neu5Ac (lawn green cylinder model) to show the heavily conserved binding motif, and b) a tPm0188Ph space filling model (coral) to 
show the orientation of the epimeric Pse5Ac7Ac sugar ring substituents (C5 acetamido-cyan, C7 acetamido-magenta, C8 hydroxyl-
red). 
 
Figure 5 Binding interactions between the Pse5Ac7Ac moiety
and Pasteurella mutocida tPm0188Ph when αCMP-Pse5Ac7Ac 3 
is docked in silico into the active site. 
Scheme 4 tPm0188Ph catalysed synthesis of Pse5Ac7Acβ-2,3-
Galβ-pNP 21. 
 
creasingly high demand for biological studies. Given that the 
chemical syntheses of such molecules are particularly arduous, 
the use of enzymes in tandem with synthetic chemistry affords 
a more expedient and efficient route to the synthesis of this 
important class of glycans. This work also provides 
Pse5Ac7Ac containing mimics of Neu5Ac capped glycocon-
jugates, enabling comparative exploration of receptor-glycan 
interactions, particularly relevant for probing the interactions 
between bacterial surfaces and Siglec proteins integral to host 
immune responses.  Notably, as no native pseudaminyltrans-
ferases have yet been shown to be active in vitro, our demon-
stration that the well-characterised, highly stable, sialyltrans-
ferase from P. multocida displays activity with α-CMP-
Pse5Ac7Ac 3, provides an impetus to study the potential turn-
over of Pse glycans by other sialic acid processing enzymes. 
Furthermore P. multocida tPm0188Ph and other promiscuous 
sialyltransferases may offer an expedient route to the synthesis 
of galactose linked Pse-glycosides present in the O-antigens of 
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